Table 4

Univariate and multivariate analysis for OS in newly diagnosed and previously untreated CLL patients

CharacteristicEventsTotalOS, y
Univariate analysis
Multivariate analysis*
Internal bootstrapping validation
Bootstrap parameters, mean
Bootstrap selection, %
MedianLCIUCIHRLCIUCIPHRLCIUCIPHRLCIUCI
BIRC3 WT 69 293 NR              85% 
BIRC3 disruption 13 3.1 6.7 5.09 2.52 10.28 < .001 3.04 1.21 7.61 .017 3.90 1.32 13.17 
Age ≤ 65 y 13 106 NR              100% 
Age > 65 y 65 200 8.5 4.6 12.4 3.57 1.95 6.52 < .001 3.88 2.08 7.22 < .001 4.41 2.21 8.87 
Rai stage 0-II 56 273 NR              97% 
Rai stage III-IV 22 33 2.7 0.6 4.9 5.44 3.31 8.97 < .001 3.10 1.72 5.59 < .001 3.44 1.83 6.47 
IGHV identity < 98% 42 208 NR              33% 
IGHV identity ≥ 98% 36 98 11.7 3.0 20.4 2.03 1.29 3.18 .002 1.24 0.72 2.12 .426 1.31 0.75 2.28 
No 11q22-q23 deletion 67 288 NR              57% 
11q22-q23 deletion 11 18 3.1 0.8 5.4 4.08 2.14 7.77 < .001 2.18 0.85 5.62 .105 2.51 0.85 5.64 
TP53 WT 61 275 NR              99% 
TP53 disruption 17 31 2.9 0.6 5.3 3.85 2.23 6.65 < .001 4.97 2.75 8.97 < .001 5.30 2.84 9.92 
NOTCH1 WT 63 273 NR              74% 
NOTCH1 mutated 15 33 3.3 1.2 14.3 2.15 1.22 3.79 .007 2.08 1.04 4.16 .038 2.31 1.13 4.76 
SF3B1 WT 71 288 NR              71% 
SF3B1 mutated 18 2.5 1.7 3.3 3.29 1.50 7.21 .003 2.49 1.08 5.72 .032 2.94 1.20 7.35 
CharacteristicEventsTotalOS, y
Univariate analysis
Multivariate analysis*
Internal bootstrapping validation
Bootstrap parameters, mean
Bootstrap selection, %
MedianLCIUCIHRLCIUCIPHRLCIUCIPHRLCIUCI
BIRC3 WT 69 293 NR              85% 
BIRC3 disruption 13 3.1 6.7 5.09 2.52 10.28 < .001 3.04 1.21 7.61 .017 3.90 1.32 13.17 
Age ≤ 65 y 13 106 NR              100% 
Age > 65 y 65 200 8.5 4.6 12.4 3.57 1.95 6.52 < .001 3.88 2.08 7.22 < .001 4.41 2.21 8.87 
Rai stage 0-II 56 273 NR              97% 
Rai stage III-IV 22 33 2.7 0.6 4.9 5.44 3.31 8.97 < .001 3.10 1.72 5.59 < .001 3.44 1.83 6.47 
IGHV identity < 98% 42 208 NR              33% 
IGHV identity ≥ 98% 36 98 11.7 3.0 20.4 2.03 1.29 3.18 .002 1.24 0.72 2.12 .426 1.31 0.75 2.28 
No 11q22-q23 deletion 67 288 NR              57% 
11q22-q23 deletion 11 18 3.1 0.8 5.4 4.08 2.14 7.77 < .001 2.18 0.85 5.62 .105 2.51 0.85 5.64 
TP53 WT 61 275 NR              99% 
TP53 disruption 17 31 2.9 0.6 5.3 3.85 2.23 6.65 < .001 4.97 2.75 8.97 < .001 5.30 2.84 9.92 
NOTCH1 WT 63 273 NR              74% 
NOTCH1 mutated 15 33 3.3 1.2 14.3 2.15 1.22 3.79 .007 2.08 1.04 4.16 .038 2.31 1.13 4.76 
SF3B1 WT 71 288 NR              71% 
SF3B1 mutated 18 2.5 1.7 3.3 3.29 1.50 7.21 .003 2.49 1.08 5.72 .032 2.94 1.20 7.35 

WT indicates wild-type; HR, hazard ratio; LCI, 95% lower confidence interval; UCI, 95% upper confidence interval; and NR, not reached.

*

Shrinkage coefficient, 0.91.

Discrimination: c-index of the original model, 0.788; bias-corrected c-index, 0.776; optimism, 0.012.

Calibration: calibration slope of the original model, 1.000; bias-corrected calibration slope, 0.894; optimism, 0.106.

Close Modal

or Create an Account

Close Modal
Close Modal